CHST4
Basic information
Region (hg38): 16:71525233-71538748
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHST4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 37 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 7 | 0 |
Variants in CHST4
This is a list of pathogenic ClinVar variants found in the CHST4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-71536729-G-A | not specified | Uncertain significance (Mar 08, 2025) | ||
16-71536729-G-T | not specified | Uncertain significance (Mar 10, 2025) | ||
16-71536745-T-A | not specified | Uncertain significance (Oct 12, 2022) | ||
16-71536792-C-G | not specified | Likely benign (Nov 09, 2021) | ||
16-71536802-G-A | not specified | Likely benign (Aug 12, 2021) | ||
16-71536810-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
16-71536816-G-A | not specified | Likely benign (Sep 10, 2024) | ||
16-71536831-C-T | not specified | Uncertain significance (Nov 26, 2024) | ||
16-71536832-G-A | not specified | Uncertain significance (Jul 25, 2024) | ||
16-71536869-G-T | not specified | Uncertain significance (Aug 16, 2021) | ||
16-71536892-T-G | not specified | Uncertain significance (Oct 04, 2024) | ||
16-71536909-G-A | not specified | Uncertain significance (Dec 20, 2021) | ||
16-71536978-G-A | not specified | Likely benign (Jul 30, 2024) | ||
16-71536993-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
16-71536999-G-A | not specified | Uncertain significance (Dec 20, 2022) | ||
16-71537030-G-A | not specified | Uncertain significance (Jul 02, 2024) | ||
16-71537044-C-G | not specified | Uncertain significance (May 05, 2023) | ||
16-71537065-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
16-71537066-G-A | not specified | Uncertain significance (Nov 11, 2024) | ||
16-71537074-T-C | not specified | Uncertain significance (Apr 16, 2024) | ||
16-71537081-C-T | not specified | Uncertain significance (Feb 03, 2025) | ||
16-71537122-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
16-71537123-G-A | not specified | Likely benign (May 27, 2022) | ||
16-71537146-A-G | not specified | Uncertain significance (Feb 28, 2025) | ||
16-71537146-A-T | not specified | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHST4 | protein_coding | protein_coding | ENST00000338482 | 1 | 13514 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.00e-9 | 0.0721 | 125682 | 0 | 61 | 125743 | 0.000243 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.256 | 231 | 242 | 0.954 | 0.0000151 | 2539 |
Missense in Polyphen | 102 | 109.74 | 0.92949 | 1077 | ||
Synonymous | 0.599 | 87 | 94.4 | 0.922 | 0.00000551 | 776 |
Loss of Function | -0.172 | 13 | 12.3 | 1.05 | 7.70e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00131 | 0.00131 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000376 | 0.000370 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.0000981 | 0.0000653 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues within mucin-associated glycans that ultimately serve as SELL ligands. SELL ligands are present in high endothelial cells (HEVs) and play a central role in lymphocyte homing at sites of inflammation. Participates in biosynthesis of the SELL ligand sialyl 6-sulfo Lewis X on receptors SPN/CD43, GLYCAM1 and MADCAM1. Also involved in biosynthesis of SELL ligand recognized by MECA-79 antibody. Plays a central role in lymphocyte trafficking during chronic inflammation. Has a catalytic preference for core 2- branched mucin-type O-glycans. Can use GlcNAcbeta1-6[Galbeta1- 3]GalNAc-pNP (core 2), GlcNAcbeta1-6ManOMe and GlcNAcbeta1-2Man oligosaccharide structures as acceptors. Has also activity toward core 3 of GlcNAcbeta1-3GalNAc-pNP. Its substrate specificity may be influenced by its subcellular location. {ECO:0000269|PubMed:10330415}.;
- Pathway
- Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human);Metapathway biotransformation Phase I and II;Post-translational protein modification;Metabolism of proteins;O-linked glycosylation of mucins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.151
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.09
Haploinsufficiency Scores
- pHI
- 0.328
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.369
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.722
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chst4
- Phenotype
- cellular phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- carbohydrate metabolic process;N-acetylglucosamine metabolic process;protein sulfation;sulfur compound metabolic process;inflammatory response;immune response;cell adhesion;cell-cell signaling;O-glycan processing
- Cellular component
- Golgi membrane;trans-Golgi network;integral component of membrane;intrinsic component of Golgi membrane
- Molecular function
- N-acetylglucosamine 6-O-sulfotransferase activity;sulfotransferase activity